Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Willis

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Diabetes Technology & Therapeutics|December 29, 2019
Temporary Reductions in Insulin Requirements Are Associated with Hypoglycemia in Type 2 DiabetesRoy Harper, Eran Bashan, Stanley G Bisgaier, et al.
American Journal of Clinical Pathology|April 20, 2011
Detection of human papillomavirus using hybrid capture 2 in oral brushings from patients with oropharyngeal squamous cell carcinomaElke A Jarboe, Mark Willis, Brandon Bentz, et al.
Science Advances|November 22, 2024
Late Archaic large-scale fisheries in the wetlands of the pre-Columbian Maya LowlandsEleanor Harrison-Buck, Samantha M Krause, Marieka Brouwer Burg, et al.
Diabetes, Obesity & Metabolism|October 30, 2022
Challenging the 50-50 rule for the basal-bolus insulin ratio in patients with type 2 diabetes who maintain stable glycaemic controlRoy Harper, Eran Bashan, Kevin J Williams, et al.
Biotechnology Progress|December 17, 2009
Application of agent-based system for bioprocess description and process improvementYing Gao, Katie Kipling, Jarka Glassey, et al.
Practical Neurology|November 26, 2024
Neurological complications of immune checkpoint inhibitors: a practical guideAisling S Carr, Frederick William Vonberg, Shiwen Koay, et al.
Multiple Sclerosis and Related Disorders|August 13, 2018
A contemporary study of mortality in the multiple sclerosis population of south east WalesKatharine Harding, Valerie Anderson, Owain Williams, et al.
JAMA Neurology|February 19, 2019
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple SclerosisKatharine Harding, Owain Williams, Mark Willis, et al.
Journal of Neurology|April 21, 2017
Seasonal variation in multiple sclerosis relapseKatharine Harding, Kate Tilling, Claire MacIver, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 20, 2017
An observational study of alemtuzumab following fingolimod for multiple sclerosisMark Willis, Owen Pearson, Zsolt Illes, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Diabetes Technology & Therapeutics|December 29, 2019
Temporary Reductions in Insulin Requirements Are Associated with Hypoglycemia in Type 2 DiabetesRoy Harper, Eran Bashan, Stanley G Bisgaier, et al.
American Journal of Clinical Pathology|April 20, 2011
Detection of human papillomavirus using hybrid capture 2 in oral brushings from patients with oropharyngeal squamous cell carcinomaElke A Jarboe, Mark Willis, Brandon Bentz, et al.
Science Advances|November 22, 2024
Late Archaic large-scale fisheries in the wetlands of the pre-Columbian Maya LowlandsEleanor Harrison-Buck, Samantha M Krause, Marieka Brouwer Burg, et al.
Diabetes, Obesity & Metabolism|October 30, 2022
Challenging the 50-50 rule for the basal-bolus insulin ratio in patients with type 2 diabetes who maintain stable glycaemic controlRoy Harper, Eran Bashan, Kevin J Williams, et al.
Biotechnology Progress|December 17, 2009
Application of agent-based system for bioprocess description and process improvementYing Gao, Katie Kipling, Jarka Glassey, et al.
Practical Neurology|November 26, 2024
Neurological complications of immune checkpoint inhibitors: a practical guideAisling S Carr, Frederick William Vonberg, Shiwen Koay, et al.
Multiple Sclerosis and Related Disorders|August 13, 2018
A contemporary study of mortality in the multiple sclerosis population of south east WalesKatharine Harding, Valerie Anderson, Owain Williams, et al.
JAMA Neurology|February 19, 2019
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple SclerosisKatharine Harding, Owain Williams, Mark Willis, et al.
Journal of Neurology|April 21, 2017
Seasonal variation in multiple sclerosis relapseKatharine Harding, Kate Tilling, Claire MacIver, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 20, 2017
An observational study of alemtuzumab following fingolimod for multiple sclerosisMark Willis, Owen Pearson, Zsolt Illes, et al.
Pageof 4